Breaking News

Upperton Pharma Solutions Investment Increases Tabletting Capabilities

New Futorque X tablet press is designed to support R&D studies and production batches

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Upperton Pharma Solutions, a UK-based contract development and manufacturing organization (CDMO) has increased its tablet manufacturing capabilities following an investment in a new state-of the-art tablet press. This investment will enhance the company’s development and manufacturing capabilities while strengthening their ability to support clients’ research, development and clinical manufacturing needs.   The new tablet press, a Futorque X by KG-Pharma is designed specifically to support both ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters